Last data update: Sep 23, 2024. (Total: 47723 publications since 2009)
Records 1-1 (of 1 Records) |
Query Trace: Neiman AB [original query] |
---|
CDC Grand Rounds: Improving medication adherence for chronic disease management - innovations and opportunities
Neiman AB , Ruppar T , Ho M , Garber L , Weidle PJ , Hong Y , George MG , Thorpe PG . MMWR Morb Mortal Wkly Rep 2017 66 (45) 1248-1251 Adherence to prescribed medications is associated with improved clinical outcomes for chronic disease management and reduced mortality from chronic conditions (1). Conversely, nonadherence is associated with higher rates of hospital admissions, suboptimal health outcomes, increased morbidity and mortality, and increased health care costs (2). In the United States, 3.8 billion prescriptions are written annually (3). Approximately one in five new prescriptions are never filled, and among those filled, approximately 50% are taken incorrectly, particularly with regard to timing, dosage, frequency, and duration (4). Whereas rates of nonadherence across the United States have remained relatively stable, direct health care costs associated with nonadherence have grown to approximately $100-$300 billion of U.S. health care dollars spent annually (5,6). Improving medication adherence is a public health priority and could reduce the economic and health burdens of many diseases and chronic conditions (7). |
- Page last reviewed:Feb 1, 2024
- Page last updated:Sep 23, 2024
- Content source:
- Powered by CDC PHGKB Infrastructure